People who have lost their vision as a result of a rare genetic disease may soon be able to have some of their sight restored, thanks to the first FDA-approved eye implant.
The implant, named the Argus II, works to wirelessly transmit images to the brain through a video camera and transmitter on a pair of glasses.
The FDA approved the device from Second Sight Medical Products for patients 25 years and older Thursday, The Associated Press reported.
While the implant does not restore vision, the FDA said the device might help the blind to see by allowing them "to detect light and dark in the environment."
The device is only approved for retintis pigmentosa, a disorder that causes gradual blindness and affects 100,0000 people in the United States.